Hi BB, Thankyou for that summary, just one point of correction,...

First 4 Last

Share
Profile

Follow
Hawkbar33

527 Posts.

889

21/12/23

08:51

Post #: 71561112
Share

Originally posted by Boursebandit: ↑

Products Summary:

The imugene product that treats blood cancers is Azer-cel. onCARlytics and the B cell pipeline are designed to treat solid tumours.CF33 is best thought of as potentially the first broad spectrum drug.
HER-Vaxx is narrow spectrum in that it can only be used to treat solid tumour that express the HER2 protein.
CF33 is the naked virus that targets only solid tumours. CF33 is infused in the Oncarlytics mix, hence this specific platform is heavily reliant on CF33/Vaxinia's effectiveness.
CF33 is already a component of Oncarlytics.
Although Oncarlytics may well have been designed to treat solid tumours, without the addition of CF33 it does not have the drug required to infect, explode and mop up the disintegrated cancer cells post contactVaxxinia is the strain with human sodium iodide symporter (hNIS) that targets only solid tumours.
Oncarlytics is the strain with hnis + cd19 shell that also only targets solid tumours.It is the blood cancer drugs that will be combined with the solid tumour drug, Oncarlytics.
That is where the crossover is. Oncarlytics is not the combination, just the solid tumour side of the combo. onCARlytics is CF33 with CD19 added.
Without CF33, the CD19 genes won’t be able to locate the tumours.

Information compiled (cut and paste ) from multiple HC contributors.

Expand

Hi BB, Thankyou for that summary, just one point of correction, my understanding is that Oncarlytics is CF33 + CD-19.
Vaxinia is the CF33 + hNIS that can pick up images of the cancer within th body.

DYOR opinion only

IMU Price at posting: 10.5¢ Sentiment: Buy Disclosure: Held
9 Upvote

0 Great analysis

Reply

Top Stories

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

HAR

Haranga jumps +7% on Lincoln acquisition

NUZ

Neurizon inks $1.5M loan against R&D Tax Rebate

IXR

Ionic Rare Earths falls -7% as momentum slips on vague production update

First 4 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 28.0¢		Change 0.000(0.00%)		Mkt cap ! $80.77M

Open	High	Low	Value	Volume
28.0¢	28.0¢	27.0¢	$461.4K	1.681M

Buyers (Bids)

No.	Vol.	Price($)
1	10000	27.5¢

Sellers (Offers)

Price($)	Vol.	No.
28.0¢	134437	7

View Market Depth

No.	Vol.	Price($)
21	229763	0.270
24	316357	0.265
29	248021	0.260
12	191057	0.255
29	245769	0.250

Price($)	Vol.	No.
0.280	134437	7
0.285	17443	2
0.290	137412	6
0.295	92217	4
0.300	283614	5

Last trade - 16.10pm 30/07/2025 (20 minute delay)

IMU (ASX) Chart

Hi BB, Thankyou for that summary, just one point of correction,...

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

Haranga jumps +7% on Lincoln acquisition

Neurizon inks $1.5M loan against R&D Tax Rebate

Ionic Rare Earths falls -7% as momentum slips on vague production update

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Hi BB, Thankyou for that summary, just one point of correction,...

Top Stories

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

Haranga jumps +7% on Lincoln acquisition

Neurizon inks $1.5M loan against R&D Tax Rebate

Ionic Rare Earths falls -7% as momentum slips on vague production update

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News